Cargando…
The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium en...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794962/ https://www.ncbi.nlm.nih.gov/pubmed/34292389 http://dx.doi.org/10.1007/s00380-021-01910-2 |
_version_ | 1784640942137933824 |
---|---|
author | van Woerden, Gijs van Veldhuisen, Dirk J. Gorter, Thomas M. Willems, Tineke P. van Empel, Vanessa P. M. Peters, Aniek Pundziute, Gabija op den Akker, Jeroen W. Rienstra, Michiel Westenbrink, B. Daan |
author_facet | van Woerden, Gijs van Veldhuisen, Dirk J. Gorter, Thomas M. Willems, Tineke P. van Empel, Vanessa P. M. Peters, Aniek Pundziute, Gabija op den Akker, Jeroen W. Rienstra, Michiel Westenbrink, B. Daan |
author_sort | van Woerden, Gijs |
collection | PubMed |
description | Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium enhancement (LGE) are at increased risk for all-cause mortality. Symptomatic HF patients with left ventricular ejection fraction (LVEF) > 40%, who underwent cardiac magnetic resonance (CMR) imaging were included. The presence of myocardial LGE lesions was visually assessed. T1 mapping was performed to calculate extracellular volume (ECV). Multivariable logistic regression analyses were used to determine associations between clinical characteristics and LGE. Cox regression analyses were used to assess the association between LGE and all-cause mortality. A total of 110 consecutive patients were included (mean age 71 ± 10 years, 49% women, median N-terminal brain natriuretic peptide (NT-proBNP) 1259 pg/ml). LGE lesions were detected in 37 (34%) patients. Previous myocardial infarction and increased LV mass index were strong and independent predictors for the presence of LGE (odds ratio 6.32, 95% confidence interval (CI) 2.07–19.31, p = 0.001 and 1.68 (1.03–2.73), p = 0.04, respectively). ECV was increased in patients with LGE lesions compared to those without (28.6 vs. 26.6%, p = 0.04). The presence of LGE lesions was associated with a fivefold increase in the incidence of all-cause mortality (hazards ratio 5.3, CI 1.5–18.1, p = 0.009), independent of age, sex, New York Heart Association (NYHA) functional class, NT-proBNP, LGE mass and LVEF. Myocardial scarring on CMR is associated with increased mortality in HF patients with LVEF > 40% and may aid in selecting a subpopulation at increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01910-2. |
format | Online Article Text |
id | pubmed-8794962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-87949622022-02-02 The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction van Woerden, Gijs van Veldhuisen, Dirk J. Gorter, Thomas M. Willems, Tineke P. van Empel, Vanessa P. M. Peters, Aniek Pundziute, Gabija op den Akker, Jeroen W. Rienstra, Michiel Westenbrink, B. Daan Heart Vessels Original Article Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium enhancement (LGE) are at increased risk for all-cause mortality. Symptomatic HF patients with left ventricular ejection fraction (LVEF) > 40%, who underwent cardiac magnetic resonance (CMR) imaging were included. The presence of myocardial LGE lesions was visually assessed. T1 mapping was performed to calculate extracellular volume (ECV). Multivariable logistic regression analyses were used to determine associations between clinical characteristics and LGE. Cox regression analyses were used to assess the association between LGE and all-cause mortality. A total of 110 consecutive patients were included (mean age 71 ± 10 years, 49% women, median N-terminal brain natriuretic peptide (NT-proBNP) 1259 pg/ml). LGE lesions were detected in 37 (34%) patients. Previous myocardial infarction and increased LV mass index were strong and independent predictors for the presence of LGE (odds ratio 6.32, 95% confidence interval (CI) 2.07–19.31, p = 0.001 and 1.68 (1.03–2.73), p = 0.04, respectively). ECV was increased in patients with LGE lesions compared to those without (28.6 vs. 26.6%, p = 0.04). The presence of LGE lesions was associated with a fivefold increase in the incidence of all-cause mortality (hazards ratio 5.3, CI 1.5–18.1, p = 0.009), independent of age, sex, New York Heart Association (NYHA) functional class, NT-proBNP, LGE mass and LVEF. Myocardial scarring on CMR is associated with increased mortality in HF patients with LVEF > 40% and may aid in selecting a subpopulation at increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01910-2. Springer Japan 2021-07-22 2022 /pmc/articles/PMC8794962/ /pubmed/34292389 http://dx.doi.org/10.1007/s00380-021-01910-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article van Woerden, Gijs van Veldhuisen, Dirk J. Gorter, Thomas M. Willems, Tineke P. van Empel, Vanessa P. M. Peters, Aniek Pundziute, Gabija op den Akker, Jeroen W. Rienstra, Michiel Westenbrink, B. Daan The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title | The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title_full | The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title_fullStr | The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title_full_unstemmed | The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title_short | The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
title_sort | clinical and prognostic value of late gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794962/ https://www.ncbi.nlm.nih.gov/pubmed/34292389 http://dx.doi.org/10.1007/s00380-021-01910-2 |
work_keys_str_mv | AT vanwoerdengijs theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT vanveldhuisendirkj theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT gorterthomasm theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT willemstinekep theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT vanempelvanessapm theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT petersaniek theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT pundziutegabija theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT opdenakkerjeroenw theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT rienstramichiel theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT westenbrinkbdaan theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT vanwoerdengijs clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT vanveldhuisendirkj clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT gorterthomasm clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT willemstinekep clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT vanempelvanessapm clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT petersaniek clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT pundziutegabija clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT opdenakkerjeroenw clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT rienstramichiel clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction AT westenbrinkbdaan clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction |